Going on a ketogenic diet might just be a sweet tooth's nightmare because this diet is all about eating food that is low in carbohydrates and high in fat.
This diet is preferred by many because it can help them shed off their belly fats, the fats that are hardest to get rid of.
Cutting down on sugar is one of the fastest ways to lose weight, according to health experts.
However, it is not easy staying true to a healthier lifestyle, and sometimes you just need the motivation to continue going through it.
Hence, many turn to their comfort food, which is often not healthy and are often sweet.
But, despair not because there are sweet food that you can still snack on, in moderate amounts of course, while staying true to the keto diet.
Dark chocolates are one that you can munch on, but you have to make sure they contain at least 70 percent of cocoa solids.
Or, you can also bake ketogenic energy balls using cocoa powder. One recipe for energy balls to try is the chocolate salted peanut butter, as suggested by the Daily Express.
You can even make this a regular addition to your keto diet because its fat and protein content are high.
According to a research, eating peanut butter might cause you to shed off some pounds.
Smoothies are sweet drinks that you can also have while on a keto diet. You just make sure that the ingredients you use, adhere to the keto diet such as avocado, coconut, berries, lemon, and lime. You can also add vanilla extract, cinnamon, or cacao for extra sweetness.
What is more, smoothies will make you feel full longer, thus lessening your food intake.
Or, you can also munch on the fruits if smoothies are not to your liking. Consuming half a cup of blackberries and raspberries will just give you four grams of sugar.
You can also bake yourself a chia pudding, which is rich in protein and fiber, making it a good fit for a keto diet.
Image credit courtesy of Theo Crazzolara/Flickr


FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 



